BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
45.34
-0.67 (-1.46%)
At close: Feb 13, 2026

SHA:688166 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
19,16712,74814,7869,53515,05118,778
Market Cap Growth
52.99%-13.79%55.07%-36.65%-19.85%44.16%
Enterprise Value
20,98514,39115,98310,60615,56018,464
Last Close Price
45.3430.1534.8522.3636.1745.02
PE Ratio
308.7667.3973.0339.7961.70110.54
Forward PE
-28.0028.0028.0043.0652.05
PS Ratio
16.249.9412.549.3714.3023.91
PB Ratio
7.575.236.124.258.6413.11
P/TBV Ratio
8.135.546.524.549.4713.58
P/OCF Ratio
85.2251.9175.9230.6385.48120.81
EV/Sales Ratio
17.7811.2213.5510.4314.7923.51
EV/EBITDA Ratio
115.2148.5258.1139.1354.9286.56
EV/EBIT Ratio
-71.6876.7545.8462.45100.84
Debt / Equity Ratio
0.930.920.910.900.520.15
Debt / EBITDA Ratio
12.857.207.717.173.101.03
Net Debt / Equity Ratio
0.690.600.480.350.32-0.21
Net Debt / EBITDA Ratio
10.324.964.212.921.99-1.40
Net Debt / FCF Ratio
-11.99-126.33-5.54-1.90-0.771.50
Asset Turnover
0.230.250.240.270.440.48
Inventory Turnover
1.621.581.741.632.332.14
Quick Ratio
0.811.061.491.921.232.39
Current Ratio
1.261.562.002.391.703.24
Return on Equity (ROE)
1.06%5.82%7.44%10.62%14.97%12.34%
Return on Assets (ROA)
0.62%2.46%2.69%3.79%6.49%7.04%
Return on Invested Capital (ROIC)
1.20%4.82%5.79%7.57%13.37%16.61%
Return on Capital Employed (ROCE)
1.20%4.90%5.10%6.00%10.40%11.90%
Earnings Yield
0.32%1.48%1.37%2.51%1.62%0.91%
FCF Yield
-0.75%-0.09%-1.41%-4.36%-4.87%-1.06%
Dividend Yield
0.21%0.32%0.27%0.51%0.33%0.19%
Payout Ratio
176.87%71.75%56.80%41.77%22.26%20.84%
Buyback Yield / Dilution
0.21%0.34%-2.10%-1.61%1.87%-11.90%
Total Shareholder Return
0.42%0.66%-1.82%-1.10%2.21%-11.71%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.